CD79A and colorectal cancer: Additionally, in the serum of colorectal cancer patients, the total level of IgA is not varied, whereas its reactivity against the RL2 O-GlcNAc antibody has been reported to be significantly increased compared to healthy individuals (Verathamjamras et al., 2021).